{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:02:35Z","timestamp":1789344155579,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Canine leishmaniosis (CanL), caused by\n                      <jats:italic>Leishmania infantum<\/jats:italic>\n                      , can be subclinical or present as a systemic, chronic, and potentially fatal disease. Treatment response in sick dogs is influenced by many factors associated with the host, the vector, and the environment. This study aimed to identify risk factors for poor prognosis in CanL, focusing on demographic, epidemiological, and clinical\/clinocopathological variables.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis was conducted on a cohort of 300 dogs with CanL diagnosed between 2000 and 2022. Two logistic regression models were built to identify variables associated with an increased risk of relapses requiring repeated leishmanicidal treatments or of mortality due to CanL. A database with several variables was used to perform the study. These included demographic (age, sex, breed, and body weight), epidemiological (living conditions, travel history, and preventative measures), and clinical variables (clinical signs reported by the pet owner and physical examination findings, antibody titers, and LeishVet clinical stage), treatment history (first-line treatment, drug combinations), and outcome, among others. All analyses were conducted using R software and applying a significance level of 5% (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Young dogs and those displaying weakness and ocular signs were more likely to develop relapses and require multiple leishmanicidal treatments, while weight loss was associated with a decreased risk. Additionally, dogs treated with miltefosine in combination with allopurinol as first-line treatment had a fivefold higher risk of needing multiple leishmanicidal treatments than those receiving meglumine antimoniate and allopurinol. Medium- to large-sized dogs had a fourfold higher mortality risk than small dogs, while this risk was almost 25 times higher in dogs in LeishVet stage IV compared with those in stage I. Mortality risk was also significantly higher in dogs displaying weakness, gastrointestinal signs, and lymphadenomegaly. Conversely, treatment with domperidone was associated with an 88% reduction in mortality risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study highlights important risk factors for poor prognosis in CanL that should be carefully considered by clinicians and researchers when managing sick dogs, particularly regarding therapy decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-07042-0","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:51:19Z","timestamp":1763463079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unveiling prognostic indicators in canine leishmaniosis: two decades of evidence"],"prefix":"10.1186","volume":"18","author":[{"given":"Juliana","family":"Sarquis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina R.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Martins","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Checa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pedro","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"G\u00f3mez-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efr\u00e9n Estevez","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"7042_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2009.05.022","author":"L Solano-Gallego","year":"2009","unstructured":"Solano-Gallego L, Koutinas A, Mir\u00f3 G, Cardoso L, Pennisi MG, Ferrer L, et al. Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet Parasitol. 2009;165.","journal-title":"Vet Parasitol"},{"key":"7042_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2009.00824.x","author":"G Mir\u00f3","year":"2009","unstructured":"Mir\u00f3 G, Oliva G, Cruz I, Ca\u00f1avate C, Mortarino M, Vischer C, et al. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Vet Dermatol. 2009;20.","journal-title":"Vet Dermatol"},{"key":"7042_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2014.03.010","author":"D Sabat\u00e9","year":"2014","unstructured":"Sabat\u00e9 D, Llin\u00e1s J, Homedes J, Sust M, Ferrer L. A single-centre, open-label, controlled, randomized clinical trial to assess the preventive efficacy of a domperidone-based treatment programme against clinical canine leishmaniasis in a high prevalence area. Prev Vet Med. 2014;115.","journal-title":"Prev Vet Med"},{"key":"7042_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s13071-021-05030-8","volume":"14","author":"MA Cavalera","year":"2021","unstructured":"Cavalera MA, Gernone F, Uva A, D\u2019Ippolito P, Roura X, Paltrinieri S, et al. Effect of domperidone (Leisguard\u00ae) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease. Parasit Vectors. 2021;14:525.","journal-title":"Parasit Vectors"},{"key":"7042_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13071-022-05537-8","volume":"15","author":"MA Cavalera","year":"2022","unstructured":"Cavalera MA, Gernone F, Uva A, Donghia R, Zizzadoro C, Zatelli A. Efficacy of domperidone plus renal diet in slowing the progression of chronic kidney disease in dogs with leishmaniosis. Parasit Vectors. 2022;15:397.","journal-title":"Parasit Vectors"},{"key":"7042_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2017.04.014","author":"S Segarra","year":"2017","unstructured":"Segarra S, Mir\u00f3 G, Montoya A, Pardo-Mar\u00edn L, Boqu\u00e9 N, Ferrer L, et al. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis. Vet Parasitol. 2017;239.","journal-title":"Vet Parasitol"},{"key":"7042_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-018-2705-z","author":"S Segarra","year":"2018","unstructured":"Segarra S, Mir\u00f3 G, Montoya A, Pardo-Mar\u00edn L, Teichenn\u00e9 J, Ferrer L, et al. Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound. Parasit Vectors. 2018;11.","journal-title":"Parasit Vectors"},{"key":"7042_CR8","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3390\/microorganisms9122601","volume":"9","author":"S Segarra","year":"2021","unstructured":"Segarra S. Nutritional Modulation of the Immune Response Mediated by Nucleotides in Canine Leishmaniosis. Microorganisms. 2021;9:2601.","journal-title":"Microorg"},{"key":"7042_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012712","volume":"18","author":"G Mir\u00f3","year":"2024","unstructured":"Mir\u00f3 G, Segarra S, Cer\u00f3n JJ, Ferrer L, Solano-Gallego L, Montell L, et al. New immunomodulatory treatment protocol for canine leishmaniosis reduces parasitemia and proteinuria. PLoS Negl Trop Dis. 2024;18:e0012712.","journal-title":"PLoS Negl Trop Dis"},{"key":"7042_CR10","unstructured":"LeishVet. A brief for the practicing veterinarian. Canine leishmaniosis. Special Edition, ALIVE 2. LeishVet Group. 2024. https:\/\/www.leishvet.org\/fact-sheet\/. Accessed 29 Dec 2024."},{"key":"7042_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2009.00823.x","author":"MN Saridomichelakis","year":"2009","unstructured":"Saridomichelakis MN. Advances in the pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications. Vet Dermatol. 2009;20.","journal-title":"Vet Dermatol"},{"key":"7042_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2010.05.025","author":"M Torres","year":"2011","unstructured":"Torres M, Bardag\u00ed M, Roura X, Zanna G, Ravera I, Ferrer L. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. Vet J. 2011;188.","journal-title":"Vet J"},{"key":"7042_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1756-3305-4-86","volume":"4","author":"L Solano-Gallego","year":"2011","unstructured":"Solano-Gallego L, Mir\u00f3 G, Koutinas A, Cardoso L, Pennisi MG, Ferrer L, et al. LeishVet guidelines for the practical management of canine leishmaniosis. Parasit Vectors. 2011;4:86.","journal-title":"Parasit Vectors"},{"key":"7042_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001153","volume":"5","author":"GF Cota","year":"2011","unstructured":"Cota GF, de Sousa MR, Rabello A. Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review. PLoS Negl Trop Dis. 2011;5.","journal-title":"PLoS Negl Trop Dis"},{"key":"7042_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.577395","author":"F Iarussi","year":"2020","unstructured":"Iarussi F, Paradies P, Foglia Manzillo V, Gizzarelli M, Caratozzolo MF, Navarro C, et al. Comparison of Two Dosing Regimens of Miltefosine, Both in Combination With Allopurinol, on Clinical and Parasitological Findings of Dogs With Leishmaniosis: A Pilot Study. Front Vet Sci. 2020;7.","journal-title":"Front Vet Sci"},{"key":"7042_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/vcp.12413","author":"S Paltrinieri","year":"2016","unstructured":"Paltrinieri S, Gradoni L, Roura X, Zatelli A, Zini E. Laboratory tests for diagnosing and monitoring canine leishmaniasis. Vet Clin Pathol. 2016;45.","journal-title":"Vet Clin Pathol"},{"key":"7042_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s13071-024-06423-1","volume":"17","author":"J Sarquis","year":"2024","unstructured":"Sarquis J, Raposo LM, Sanz CR, Montoya A, Barrera JP, Checa R, et al. Relapses in canine leishmaniosis: risk factors identified through mixed-effects logistic regression. Parasit Vectors. 2024;17:357.","journal-title":"Parasit Vectors"},{"key":"7042_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2014.09.002","author":"C Noli","year":"2014","unstructured":"Noli C, Saridomichelakis MN. An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L.\u2009chagasi). Vet J. 2014;202.","journal-title":"Vet J"},{"key":"7042_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00558-12","author":"T Di Muccio","year":"2012","unstructured":"Di Muccio T, Veronesi F, Antognoni MT, Onofri A, Piergili Fioretti D, Gramiccia M. Diagnostic Value of Conjunctival Swab Sampling Associated with Nested PCR for Different Categories of Dogs Naturally Exposed to Leishmania infantum Infection. J Clin Microbiol. 2012;50.","journal-title":"J Clin Microbiol"},{"key":"7042_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2008.12.009","author":"L Manna","year":"2009","unstructured":"Manna L, Reale S, Vitale F, Gravino AE. Evidence for a relationship between Leishmania load and clinical manifestations. Res Vet Sci. 2009;87.","journal-title":"Res Vet Sci"},{"key":"7042_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1756-3305-4-57","volume":"4","author":"V Mart\u00ednez","year":"2011","unstructured":"Mart\u00ednez V, Quilez J, Sanchez A, Roura X, Francino O, Altet L. Canine Leishmaniasis: the key points for qPCR result interpretation. Parasit Vectors. 2011;4:57.","journal-title":"Parasit Vectors"},{"key":"7042_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/1040638718824140","author":"B Bruno","year":"2019","unstructured":"Bruno B, Romano A, Zanatta R, Spina S, Mignone W, Ingravalle F, et al. Serum indirect immunofluorescence assay and real-time PCR results in dogs affected by Leishmania infantum: evaluation before and after treatment at different clinical stages. J Vet Diagn Invest. 2019;31.","journal-title":"J Vet Diagn Invest"},{"key":"7042_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s13071-014-0460-3","volume":"7","author":"M Ceccarelli","year":"2014","unstructured":"Ceccarelli M, Galluzzi L, Sisti D, Bianchi B, Magnani M. Application of qPCR in conjunctival swab samples for the evaluation of canine leishmaniasis in borderline cases or disease relapse and correlation with clinical parameters. Parasit Vectors. 2014;7:460.","journal-title":"Parasit Vectors"},{"key":"7042_CR24","doi-asserted-by":"publisher","DOI":"10.1892\/0891-6640(2006)20[495:DOLIII]2.0.CO;2","author":"A Rodr\u00edguez","year":"2006","unstructured":"Rodr\u00edguez A, Solano-Gallego L, Ojeda A, Quintana J, Riera C, G\u00e1llego M, et al. Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment. J Vet Intern Med. 2006;20.","journal-title":"J Vet Intern Med"},{"key":"7042_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13071-016-1519-0","volume":"9","author":"L Solano-Gallego","year":"2016","unstructured":"Solano-Gallego L, Di Filippo L, Ordeix L, Planellas M, Roura X, Altet L, et al. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease. Parasit Vectors. 2016;9:235.","journal-title":"Parasit Vectors"},{"key":"7042_CR26","first-page":"430","volume":"8","author":"GD Santos","year":"2023","unstructured":"Santos G de A, Sousa JM, Aguiar AHBM de, Torres KCS, Coelho AJS, Ferreira AL, et al. Systematic Review of Treatment Failure and Clinical Relapses in Leishmaniasis from a Multifactorial Perspective: Clinical Aspects, Factors Associated with the Parasite and Host. TropicalMed. 2023;8:430.","journal-title":"Tropical Med Infect Dis"},{"key":"7042_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2013.05.015","author":"C Maia","year":"2013","unstructured":"Maia C, Nunes M, Marques M, Henriques S, Rol\u00e3o N, Campino L. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs. Exp Parasitol. 2013;135.","journal-title":"Exp Parasitol"},{"key":"7042_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004341","volume":"10","author":"D Yasur-Landau","year":"2016","unstructured":"Yasur-Landau D, Jaffe CL, David L, Baneth G. Allopurinol resistance in Leishmania infantum from dogs with disease relapse. PLoS Negl Trop Dis. 2016;10:e0004341.","journal-title":"PLoS Negl Trop Dis"},{"key":"7042_CR29","doi-asserted-by":"publisher","DOI":"10.1590\/s1984-29612024012","volume":"33","author":"G Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves G, Campos MP de, Gon\u00e7alves AS, Figueiredo FB. Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum. Rev Bras Parasitol Vet. 2024;33:e015023.","journal-title":"Rev Bras Parasitol Vet"},{"key":"7042_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4017(02)00115-2","author":"G Baneth","year":"2002","unstructured":"Baneth G, Shaw SE. Chemotherapy of canine leishmaniosis. Vet Parasitol. 2002;106.","journal-title":"Vet Parasitol"},{"key":"7042_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2024.03.006","author":"CR Sanz","year":"2024","unstructured":"Sanz CR, Sarquis J, Daza M\u00c1, Mir\u00f3 G. Exploring the impact of epidemiological and clinical factors on the progression of canine leishmaniosis by statistical and whole genome analyses: from breed predisposition to comorbidities. Int J Parasitol. 2024;S0020751924000584.","journal-title":"Int J Parasitol"},{"key":"7042_CR32","first-page":"49","volume":"1","author":"KS Rock","year":"2016","unstructured":"Rock KS, Quinnell RJ, Medley GF, Courtenay O. Chapter two - Progress in the mathematical modelling of visceral leishmaniasis. Adv Parasitol. 2016;94.","journal-title":"Adv Parasitol"},{"key":"7042_CR33","first-page":"55","volume":"2019","author":"KE Creevy","year":"2019","unstructured":"Creevy KE, Grady J, Little SE, Moore GE, Strickler BG, Thompson S, et al. 2019 AAHA Canine Life Stage Guidelines. J Am Anim Hosp Assoc. 2019;55.","journal-title":"J Am Anim Hosp Assoc"},{"key":"7042_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11259-006-0010-3","volume":"30","author":"F Mancianti","year":"2006","unstructured":"Mancianti F, Franceschi A. Canine Leishmaniasis: Parasitological Follow-up of the Treated Subject. Vet Res Commun. 2006;30.","journal-title":"Vet Res Commun"},{"key":"7042_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rvsc.2017.10.011","volume":"117","author":"A Mel\u00e9ndez-Lazo","year":"2018","unstructured":"Mel\u00e9ndez-Lazo A, Ordeix L, Planellas M, Pastor J, Solano-Gallego L. Clinicopathological findings in sick dogs naturally infected with Leishmania infantum: Comparison of five different clinical classification systems. Res Vet Sci. 2018;117.","journal-title":"Res Vet Sci"},{"key":"7042_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-6849-3","volume-title":"Applied predictive modeling","author":"M Kuhn","year":"2013","unstructured":"Kuhn M, Johnson K. Applied Predictive Modeling. New York, NY: Springer; 2013."},{"key":"7042_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code for Biol Med. 2008;3:17.","journal-title":"Source Code Biol Med"},{"key":"7042_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/fmch-2019-000262","volume":"8","author":"MZI Chowdhury","year":"2020","unstructured":"Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health. 2020;8:e000262.","journal-title":"Fam Med Community Health"},{"key":"7042_CR39","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/03610928008827941","volume":"9","author":"DW Hosmer","year":"1980","unstructured":"Hosmer DW, Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Commun Stat Theory and Methods. 1980;9.","journal-title":"Commun Stat Theory and Methods"},{"key":"7042_CR40","unstructured":"R Core Team. (2024) The R Project for Statistical Computing. R: The R Project for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 10 Jun 2024."},{"key":"7042_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2007.09.003","author":"S Miranda","year":"2008","unstructured":"Miranda S, Roura X, Picado A, Ferrer L, Ramis A. Characterization of sex, age, and breed for a population of canine leishmaniosis diseased dogs. Res Vet Sci. 2008;85.","journal-title":"Res Vet Sci"},{"key":"7042_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2010.02.009","author":"R G\u00e1lvez","year":"2010","unstructured":"G\u00e1lvez R, Descalzo MA, Mir\u00f3 G, Jim\u00e9nez MI, Mart\u00edn O, Dos Santos-Brandao F, et al. Seasonal trends and spatial relations between environmental\/meteorological factors and leishmaniosis sand fly vector abundances in Central Spain. Acta Trop. 2010;115.","journal-title":"Acta Trop"},{"key":"7042_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/vetr.451","volume":"189","author":"M Cabr\u00e9","year":"2021","unstructured":"Cabr\u00e9 M, Planellas M, Ordeix L, Solano-Gallego L. Is signalment associated with clinicopathological findings in dogs with leishmaniosis? Vet Rec. 2021;189:e451.","journal-title":"Vet Rec"},{"key":"7042_CR44","doi-asserted-by":"publisher","DOI":"10.1590\/s1984-29612023029","volume":"32","author":"SS Silva","year":"2023","unstructured":"Silva SS, Macedo LO de, Oliveira JCP de, Alves LC, Carvalho GA de, Ramos RAN. Canine visceral leishmaniasis: risk factors and spatial analysis in an endemic area of Northeastern Brazil. Rev Bras Parasitol Vet. 2023;32:e003223.","journal-title":"Rev Bras Parasitol Vet"},{"key":"7042_CR45","first-page":"100851","volume":"39","author":"AT Dos Reis","year":"2023","unstructured":"Dos Reis AT, do Carmo Silva CF, Rocha TB, Coutinho DJB, da Costa AP, Costa FB, et al. Exposure to and infection by Leishmania infantum among domestic dogs in an area of the Cerrado biome, Maranh\u00e3o, Brazil. Vet Parasitol Reg Stud Reports. 2023;39:100851.","journal-title":"Vet Parasitol Reg Stud Rep"},{"key":"7042_CR46","doi-asserted-by":"publisher","first-page":"106811","DOI":"10.1016\/j.actatropica.2022.106811","volume":"239","author":"L Chiyo","year":"2023","unstructured":"Chiyo L, Dos Santos AG, de Souza AB, Rivas AV, Valle SB, Sev\u00e1 A da P, et al. Cross-sectional spatial and epidemiological analysis of canine visceral leishmaniasis cases in the triple border region, Brazil, Argentina and Paraguay, between 2015 and 2020. Acta Trop. 2023;239:106811.","journal-title":"Acta Trop"},{"key":"7042_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2009.11.025","author":"R G\u00e1lvez","year":"2010","unstructured":"G\u00e1lvez R, Mir\u00f3 G, Descalzo MA, Nieto J, Dado D, Mart\u00edn O, et al. Emerging trends in the seroprevalence of canine leishmaniosis in the Madrid region (central Spain). Vet Parasitol. 2010;169.","journal-title":"Vet Parasitol"},{"key":"7042_CR48","doi-asserted-by":"publisher","first-page":"1368929","DOI":"10.3389\/fvets.2024.1368929","volume":"11","author":"J Sarquis","year":"2024","unstructured":"Sarquis J, Parody N, Montoya A, Cacheiro-Llaguno C, Barrera JP, Checa R, et al. Clinical validation of circulating immune complexes for use as a diagnostic marker of canine leishmaniosis. Front Vet Sci. 2024;11:1368929.","journal-title":"Front Vet Sci"},{"key":"7042_CR49","doi-asserted-by":"publisher","first-page":"108921","DOI":"10.1016\/j.vetpar.2019.108921","volume":"274","author":"N Parody","year":"2019","unstructured":"Parody N, Cacheiro-Llaguno C, Osuna C, Renshaw-Calder\u00f3n A, Alonso C, Carn\u00e9s J. Circulating immune complexes levels correlate with the progression of canine leishmaniosis in naturally infected dogs. Vet Parasitol. 2019;274:108921.","journal-title":"Vet Parasitol"},{"key":"7042_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13071-022-05226-6","volume":"15","author":"A M\u00fcller","year":"2022","unstructured":"M\u00fcller A, Montoya A, Escacena C, de la Cruz M, Junco A, Iriso A, et al. Leishmania infantum infection serosurveillance in stray dogs inhabiting the Madrid community: 2007-2018. Parasit Vectors. 2022;15:96.","journal-title":"Parasit Vectors"},{"key":"7042_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2008.05.003","author":"G Mir\u00f3","year":"2008","unstructured":"Mir\u00f3 G, Cardoso L, Pennisi MG, Oliva G, Baneth G. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part two. Trends Parasitol. 2008;24.","journal-title":"Trends Parasitol"},{"key":"7042_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2018.03.002","author":"G Mir\u00f3","year":"2018","unstructured":"Mir\u00f3 G, L\u00f3pez-V\u00e9lez R. Clinical management of canine leishmaniosis versus human leishmaniasis due to Leishmania infantum: Putting \u201cOne Health\u201d principles into practice. Vet Parasitol. 2018;254.","journal-title":"Vet Parasitol"},{"key":"7042_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-009-1375-3","author":"M Mateo","year":"2009","unstructured":"Mateo M, Maynard L, Vischer C, Bianciardi P, Mir\u00f3 G. Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis. Parasitol Res. 2009;105.","journal-title":"Parasitol Res"},{"key":"7042_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313167","volume":"20","author":"AdS Rosar","year":"2025","unstructured":"Rosar AdS, Martins CL, Menin A, Reck C, Grisard EC, Wagner G, et al. Clinical, histopathological and parasitological follow-up of dogs naturally infected by Leishmania infantum before and after miltefosine treatment and associated therapies. PLoS ONE. 2025, 20(1): e0313167.","journal-title":"PLoS ONE"},{"key":"7042_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2008.04.001","author":"G Baneth","year":"2008","unstructured":"Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L. Canine leishmaniosis \u2013 new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 2008;24.","journal-title":"Trends Parasitol"},{"key":"7042_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-04080-8","volume":"13","author":"A Montoya","year":"2020","unstructured":"Montoya A, G\u00e1lvez R, Checa R, Sarquis J, Plaza A, Barrera JP, et al. Latest trends in L. infantum infection in dogs in Spain, Part II: current clinical management and control according to a national survey of veterinary practitioners. Parasit Vectors. 2020;13:205.","journal-title":"Parasit Vectors"},{"key":"7042_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-024-06357-8","author":"P Olmeda","year":"2024","unstructured":"Olmeda P, D\u00edaz-Rega\u00f1\u00f3n D, Villaescusa A, Amusategui I, Garc\u00eda A, Herrero F, et al. Twenty-year evolution of Leishmania infantum infection in dogs in Valdeorras (Galicia, Northwestern Spain): implication of climatic factors and preventive measures. Parasit Vectors. 2024;17.","journal-title":"Parasit Vectors"},{"key":"7042_CR58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpddr.2016.04.003","volume":"6","author":"V G\u00f3mez P\u00e9rez","year":"2016","unstructured":"G\u00f3mez P\u00e9rez V, Garc\u00eda-Hernandez R, Corpas-L\u00f3pez V, Tom\u00e1s AM, Mart\u00edn-Sanchez J, Castanys S, et al. Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum. Int J Parasitol Drugs Drug Resist. 2016;6:133\u20139.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7042_CR59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s13071-021-05100-x","volume":"14","author":"G Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves G, Campos MP, Gon\u00e7alves AS, Medeiros LCS, Figueiredo FB. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol. Parasit Vectors. 2021;14:599.","journal-title":"Parasit Vectors"},{"key":"7042_CR60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1756-3305-7-111","volume":"7","author":"L Solano-Gallego","year":"2014","unstructured":"Solano-Gallego L, Villanueva-Saz S, Carbonell M, Trotta M, Furlanello T, Natale A. Serological diagnosis of canine leishmaniosis: comparison of three commercial ELISA tests (Leiscan, ID Screen and Leishmania 96), a rapid test (Speed Leish K) and an in-house IFAT. Parasit Vectors. 2014;7:111.","journal-title":"Parasit Vectors"},{"key":"7042_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-015-0896-0","author":"L Manna","year":"2015","unstructured":"Manna L, Corso R, Galiero G, Cerrone A, Muzj P, Gravino AE. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol. Parasit Vectors. 2015;8.","journal-title":"Parasit Vectors"},{"key":"7042_CR62","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.44.4.1318-1322.2006","author":"G Oliva","year":"2006","unstructured":"Oliva G, Scalone A, Foglia Manzillo V, Gramiccia M, Pagano A, Di Muccio T, et al. Incidence and Time Course of Leishmania infantum Infections Examined by Parasitological, Serologic, and Nested-PCR Techniques in a Cohort of Na\u00efve Dogs Exposed to Three Consecutive Transmission Seasons. J Clin Microbiol. 2006;44.","journal-title":"J Clin Microbiol"},{"key":"7042_CR63","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/vr.100637","volume":"171","author":"K Geisweid","year":"2012","unstructured":"Geisweid K, Mueller R, Sauter-Louis C, Hartmann K. Prognostic analytes in dogs with Leishmania infantum infection living in a non-endemic area. Vet Rec. 2012;171:399.","journal-title":"Vet Rec"},{"key":"7042_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.rvsc.2020.02.004","volume":"1","author":"AJ Toepp","year":"2020","unstructured":"Toepp AJ, Petersen CA. The balancing act: Immunology of leishmaniosis. Res Vet Sci. 2020;130.","journal-title":"Res Vet Sci"},{"key":"7042_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002225","volume":"7","author":"V Foglia Manzillo","year":"2013","unstructured":"Foglia Manzillo V, Di Muccio T, Cappiello S, Scalone A, Paparcone R, Fiorentino E, et al. Prospective study on the incidence and progression of clinical signs in na\u00efve dogs naturally infected by Leishmania infantum. PLoS Negl Trop Dis. 2013;7:e2225.","journal-title":"PLoS Negl Trop Dis"},{"key":"7042_CR66","doi-asserted-by":"publisher","DOI":"10.14202\/vetworld.2016.633-637","author":"SD Pietro","year":"2016","unstructured":"Pietro SD, Bosco VRF, Crin\u00f2 C, Francaviglia F, Giudice E. Prevalence, type, and prognosis of ocular lesions in shelter and owned client dogs naturally infected by Leishmania infantum. Vet World. 2016;9.","journal-title":"Vet World"},{"key":"7042_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1463-5224.2000.00106.x","volume":"3","author":"MT Pe\u00f1a","year":"2000","unstructured":"Pe\u00f1a MT., Roura X, Davidson MG. Ocular and periocular manifestations of leishmaniasis in dogs: 105 cases (1993\u20131998). Vet Ophthalmol. 2000;3.","journal-title":"Vet Ophthalmol"},{"key":"7042_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2016.08.006","author":"RBP Torrecilha","year":"2016","unstructured":"Torrecilha RBP, Utsunomiya YT, Bosco AM, Almeida BF, Pereira PP, Narciso LG, et al. Correlations between peripheral parasite load and common clinical and laboratory alterations in dogs with visceral leishmaniasis. Prev Vet Med. 2016;132.","journal-title":"Prev Vet Med"},{"key":"7042_CR69","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s15010-003-3139-9","volume":"31","author":"GL Werneck","year":"2003","unstructured":"Werneck GL, Batista MSA, Gomes JRB, Costa DL, Costa CHN. Prognostic Factors for Death from Visceral Leishmaniasis in Teresina, Brazil. Infection. 2003;31.","journal-title":"Infection"},{"key":"7042_CR70","doi-asserted-by":"publisher","first-page":"101897","DOI":"10.1016\/j.cimid.2022.101897","volume":"90","author":"MC L\u00f3pez","year":"2022","unstructured":"L\u00f3pez MC, Bertolani C, Sainz A, Tabar MD, Roura X. Chronic diarrhea secondary to canine leishmaniosis: Case series. Comp Immunol Microbiol Infect Dis 2022;90\u201391:101897.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"7042_CR71","doi-asserted-by":"publisher","DOI":"10.1177\/0300985814521248","author":"AF Koutinas","year":"2014","unstructured":"Koutinas AF, Koutinas CK. Pathologic Mechanisms Underlying the Clinical Findings in Canine Leishmaniosis due to Leishmania infantum\/chagasi. Vet Pathol. 2014;51.","journal-title":"Vet Pathol"},{"key":"7042_CR72","doi-asserted-by":"publisher","first-page":"102041","DOI":"10.1016\/j.cimid.2023.102041","volume":"101","author":"CC Molina","year":"2023","unstructured":"Molina CC, Dias MJ, Domingues TD, Englar RE, Leal RO. Clinical findings and prognostic factors for mortality in hospitalized dogs with leishmaniosis: a retrospective study. Comp Immunol Microbiol Infect Dis. 2023;101:102041.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"7042_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13071-023-05777-2","volume":"16","author":"MK de Jong","year":"2023","unstructured":"de Jong MK, Rappoldt A, Broere F, Piek CJ. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy. Parasit Vectors. 2023;16:163.","journal-title":"Parasit Vectors"},{"key":"7042_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005910","volume":"11","author":"D Yasur-Landau","year":"2017","unstructured":"Yasur-Landau D, Jaffe CL, Doron-Faigenboim A, David L, Baneth G. Induction of allopurinol resistance in Leishmania infantum isolated from dogs. PLoS Negl Trop Dis. 2017;11:e0005910.","journal-title":"PLoS Negl Trop Dis"},{"key":"7042_CR75","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijpddr.2018.08.002","volume":"8","author":"D Yasur-Landau","year":"2018","unstructured":"Yasur-Landau D, Jaffe CL, David L, Doron-Faigenboim A, Baneth G. Resistance of Leishmania infantum to allopurinol is associated with chromosome and gene copy number variations including decrease in the S-adenosylmethionine synthetase (METK) gene copy number. Int J Parasitol Drugs Drug Resist. 2018;8.","journal-title":"Int J Parasitol Drug Resist"},{"key":"7042_CR76","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s13071-024-06583-0","volume":"17","author":"I Sch\u00e4fer","year":"2024","unstructured":"Sch\u00e4fer I, Faucher M, Nachum-Biala Y, Ferrer L, Carrasco M, Kehl A, et al. Evidence for in vivo resistance against allopurinol in a dog infected with Leishmania infantum by reduction in copy numbers of the S-adenosylmethionine synthetase (METK) gene. Parasit Vectors. 2024;17:506.","journal-title":"Parasit Vectors"},{"key":"7042_CR77","first-page":"330","volume":"13","author":"T Cavaliero","year":"1999","unstructured":"Cavaliero T, Arnold P, Mathis A, Glaus T, Hofmann-Lehmann R, Deplazes P. Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum. J Vet Intern Med. 1999;13.","journal-title":"J Vet Intern Med"},{"key":"7042_CR78","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1756-3305-4-52","volume":"4","author":"G Mir\u00f3","year":"2011","unstructured":"Mir\u00f3 G, G\u00e1lvez R, Fraile C, Descalzo MA, Molina R. Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments. Parasit Vectors. 2011;4:52.","journal-title":"Parasit Vectors"},{"key":"7042_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2012.01.005","author":"P Paradies","year":"2012","unstructured":"Paradies P, Sasanelli M, Amato ME, Greco B, De Palo P, Lubas G. Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area. Res Vet Sci. 2012;93.","journal-title":"Res Vet Sci"},{"key":"7042_CR80","doi-asserted-by":"publisher","first-page":"107947","DOI":"10.1016\/j.exppara.2020.107947","volume":"217","author":"\u00c1F de Lima Ruy Dias","year":"2020","unstructured":"Dias \u00c1F de LR, Ayres E da CBS, de Oliveira Martins DT, Maruyama FH, de Oliveira RG, de Carvalho MR, et al. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral Leishmaniasis. Exp Parasitol. 2020;217:107947.","journal-title":"Exp Parasitol"},{"key":"7042_CR81","doi-asserted-by":"publisher","DOI":"10.1590\/s1984-29612022040","volume":"31","author":"ED Ayres","year":"2022","unstructured":"Ayres E da CBS, Dias \u00c1F de LR, Monteiro BRG, Pazzini SS, Barbosa MEC, Silva EB da, et al. Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis. Rev Bras Parasitol Vet. 2022;31:e007222.","journal-title":"Rev Bras Parasitol Vet"},{"key":"7042_CR82","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1939-1676.1999.tb01455.x","volume":"13","author":"P Denerolle","year":"1999","unstructured":"Denerolle P, Bourdoiseau G. Combination Allopurinol and Antimony Treatment versus Antimony Alone and Allopurinol Alone in the Treatment of Canine Leishmaniasis (96 Cases). J Vet Inter Med. 1999;13.","journal-title":"J Vet Intern Med"},{"key":"7042_CR83","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0304-4017(01)00399-5","volume":"98","author":"AF Koutinas","year":"2001","unstructured":"Koutinas AF, Saridomichelakis MN, Mylonakis ME, Leontides L, Polizopoulou Z, Billinis C, et al. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Vet Parasitol. 2001;98.","journal-title":"Vet Parasitol"},{"key":"7042_CR84","doi-asserted-by":"publisher","first-page":"100048","DOI":"10.1016\/j.jvacx.2019.100048","volume":"9","author":"LF Nascimento","year":"2020","unstructured":"Nascimento LFM, Miranda DFH, Moura LD, Pinho FA, Werneck GL, Khouri R, et al. Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs. Vaccine X. 2019;4:100048.","journal-title":"Vaccine X"},{"key":"7042_CR85","first-page":"48","volume":"72","author":"Aroch","year":"2017","unstructured":"Aroch et al. Concurrent Epistaxis, Retinal Bleeding and Hypercoagulability in a Dog with Visceral Leishmaniosis. Isr J Vet Med. 2017;72.","journal-title":"Isr J Vet Med"},{"key":"7042_CR86","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s13071-023-05903-0","volume":"16","author":"M Baxarias","year":"2023","unstructured":"Baxarias M, Donato G, Mateu C, Salichs M, Homedes J, Mir\u00f3 G, et al. A blinded, randomized and controlled multicenter clinical trial to assess the efficacy and safety of Leisguard\u00ae as an immunotherapeutic treatment for healthy Leishmania infantum-seropositive dogs. Parasit Vectors. 2023;16:344.","journal-title":"Parasit Vectors"},{"key":"7042_CR87","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760180301","volume":"113","author":"BL Travi","year":"2018","unstructured":"Bl T, G M. Use of domperidone in canine visceral leishmaniasis: gaps in veterinary knowledge and epidemiological implications. Mem Inst Oswaldo Cruz;113.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"7042_CR88","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.3390\/molecules25173918","volume":"25","author":"MA Dea-Ayuela","year":"2020","unstructured":"Dea-Ayuela MA, Segarra S, Serrano DR, Bol\u00e1s-Fern\u00e1ndez F. Nucleotides and AHCC Enhance Th1 Responses In Vitro in Leishmania-Stimulated\/Infected Murine Cells. Molecules. 2020;25:3918.","journal-title":"Mol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07042-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-07042-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07042-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:03:59Z","timestamp":1763507039000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-07042-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7042"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-07042-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6545825\/v1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No live animals were involved in this research. We used existing data from medical records and laboratory reports, focusing exclusively on the analysis of anonymized data. Permission to access the data was obtained from the chief of service at the Veterinary teaching hospital where the consultations took place.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}